Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 201

Similar articles for PubMed (Select 19995924)

1.

Antiviral efficacy of the novel compound BIT225 against HIV-1 release from human macrophages.

Khoury G, Ewart G, Luscombe C, Miller M, Wilkinson J.

Antimicrob Agents Chemother. 2010 Feb;54(2):835-45. doi: 10.1128/AAC.01308-09. Epub 2009 Dec 7.

2.

The HIV-1 Vpu viroporin inhibitor BIT225 does not affect Vpu-mediated tetherin antagonism.

Kuhl BD, Cheng V, Donahue DA, Sloan RD, Liang C, Wilkinson J, Wainberg MA.

PLoS One. 2011;6(11):e27660. doi: 10.1371/journal.pone.0027660. Epub 2011 Nov 14.

3.

Potential new anti-human immunodeficiency virus type 1 compounds depress virus replication in cultured human macrophages.

Ewart GD, Nasr N, Naif H, Cox GB, Cunningham AL, Gage PW.

Antimicrob Agents Chemother. 2004 Jun;48(6):2325-30.

4.

T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1.

Ojwang JO, Buckheit RW, Pommier Y, Mazumder A, De Vreese K, Esté JA, Reymen D, Pallansch LA, Lackman-Smith C, Wallace TL, et al.

Antimicrob Agents Chemother. 1995 Nov;39(11):2426-35.

7.

Vpu serine 52 dependent counteraction of tetherin is required for HIV-1 replication in macrophages, but not in ex vivo human lymphoid tissue.

Schindler M, Rajan D, Banning C, Wimmer P, Koppensteiner H, Iwanski A, Specht A, Sauter D, Dobner T, Kirchhoff F.

Retrovirology. 2010 Jan 15;7:1. doi: 10.1186/1742-4690-7-1.

8.

Inhibition of HIV replication and macrophage colony-stimulating factor production in human macrophages by antiretroviral agents.

Kutza J, Fields K, Grimm TA, Clouse KA.

AIDS Res Hum Retroviruses. 2002 Jun 10;18(9):619-25.

PMID:
12079557
9.

Extracellular high mobility group box-1 inhibits R5 and X4 HIV-1 strains replication in mononuclear phagocytes without induction of chemokines and cytokines.

Cassetta L, Fortunato O, Adduce L, Rizzi C, Hering J, Rovere-Querini P, Bianchi ME, Alfano M, Poli G.

AIDS. 2009 Mar 13;23(5):567-77. doi: 10.1097/QAD.0b013e328325a47e.

PMID:
19194273
10.

The compound 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid inhibits HIV-1 replication by targeting the enzyme reverse transcriptase.

Souza TM, Cirne-Santos CC, Rodrigues DQ, Abreu CM, Tanuri A, Ferreira VF, Marques IP, de Souza MC, Fontes CF, Frugulhetti IC, Bou-Habib DC.

Curr HIV Res. 2008 May;6(3):209-17.

PMID:
18473784
11.

Effects of vpu start-codon mutations on human immunodeficiency virus type 1 replication in macrophages.

Richards KH, Clapham PR.

J Gen Virol. 2007 Oct;88(Pt 10):2780-92.

PMID:
17872532
12.

High-throughput assay to identify inhibitors of Vpu-mediated down-regulation of cell surface BST-2.

Zhang Q, Liu Z, Mi Z, Li X, Jia P, Zhou J, Yin X, You X, Yu L, Guo F, Ma J, Liang C, Cen S.

Antiviral Res. 2011 Sep;91(3):321-9. doi: 10.1016/j.antiviral.2011.07.007. Epub 2011 Jul 14.

PMID:
21777622
13.

Efficacy of Tat-conjugated ritonavir-loaded nanoparticles in reducing HIV-1 replication in monocyte-derived macrophages and cytocompatibility with macrophages and human neurons.

Borgmann K, Rao KS, Labhasetwar V, Ghorpade A.

AIDS Res Hum Retroviruses. 2011 Aug;27(8):853-62. doi: 10.1089/AID.2010.0295. Epub 2011 Feb 2.

14.

Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir.

Aquaro S, Caliò R, Balzarini J, Bellocchi MC, Garaci E, Perno CF.

Antiviral Res. 2002 Aug;55(2):209-25. Review.

PMID:
12103427
15.

Human immunodeficiency virus type-1 (HIV-1) infection increases the sensitivity of macrophages and THP-1 cells to cytotoxicity by cationic liposomes.

Konopka K, Pretzer E, Felgner PL, Düzgüneş N.

Biochim Biophys Acta. 1996 Jul 24;1312(3):186-96.

PMID:
8703987
16.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
17.

Antiviral profile of HIV inhibitors in macrophages: implications for therapy.

Perno CF, Balestra E, Francesconi M, Abdelahad D, Caliò R, Balzarini J, Aquaro S.

Curr Top Med Chem. 2004;4(9):1009-15. Review.

PMID:
15134554
19.

The thalidomide analogue CC-3052 inhibits HIV-1 and tumour necrosis factor-alpha (TNF-alpha) expression in acutely and chronically infected cells in vitro.

La Maestra L, Zaninoni A, Marriott JB, Lazzarin A, Dalgleish AG, Barcellini W.

Clin Exp Immunol. 2000 Jan;119(1):123-9.

20.

Cystamine inhibits HIV type 1 replication in cells of monocyte/macrophage and T cell lineages.

Ho WZ, Zhu XH, Song L, Lee HR, Cutilli JR, Douglas SD.

AIDS Res Hum Retroviruses. 1995 Apr;11(4):451-9.

PMID:
7632461
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk